Although the precise mechanism is required further investigation, tumor cell-induced STAT3 activation may largely be responsible for the suppression of IFNγ/STAT1 signaling and Th1 responses in mice treated with the TLR4/9 agonist complex after tumor cell inoculation. Here, STAT1 is linked to neoplasm.